In compliance with Regulation 24A of SEBI (LODR) Regulations 2015, Board appointment M/s. Mohammed Tausif Shamim & Co., Practicing Company Secretary, Kolkata as Secretarial Auditor of the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gennex Laboratories has submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2025, as required under Regulation 24A of SEBI (LODR) Regulations. The report was issued by M/s. Mohammad Tausif Shamim & Co., Practicing Company Secretary, Kolkata. The auditor confirmed compliance across most areas, including Secretarial Standards, insider trading regulations, related party transactions, and timely disclosures. One non-compliance was flagged under SEBI Master Circular dated November 11, 2024, regarding the composition of the Board of Directors for the quarter ended December 31, 2024 — specifically the requirement to have a woman Independent Director was not met throughout that quarter. The company had submitted a waiver application to BSE on March 28, 2025. BSE had also suo moto withdrawn earlier fines levied under Regulation 17(1) for the quarter ended September 30, 2024. No resignation of statutory auditors occurred during the period.
This is a routine regulatory compliance filing with no major red flags. The flagged Board composition issue for one quarter is a minor governance matter that the company is already addressing via a waiver application, and prior fines have already been withdrawn by BSE. Shareholders are unlikely to see any meaningful stock price impact from this disclosure.